<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04013100</url>
  </required_header>
  <id_info>
    <org_study_id>18-006</org_study_id>
    <nct_id>NCT04013100</nct_id>
  </id_info>
  <brief_title>Cohort Trial on Perioperative Localization Techniques of Parathyroid Adenomas</brief_title>
  <acronym>ParaCatI</acronym>
  <official_title>Cohort Trial on Perioperative Localization Techniques of Parathyroid Adenomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IHU Strasbourg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IHU Strasbourg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective database of consecutive patients with hyperparathyroidism subject to surgery is
      created. Preoperative workup and operative findings are recorded in this registry to allow
      comprehensive analysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a non-interventional, prospective, monocentric, non-randomized trial. All patients
      with biochemically confirmed Primary Hyperparathyroidism (PHPT) who are scheduled for
      elective parathyroidectomy in the Endocrine and Digestive Surgery Unit of the University
      Hospital of Strasbourg are considered. Data concerning the age, the operative date, the
      results of the pre-operative biological work-up (plasma calcium, phosphor, parathyroid
      hormone (PTH) level, vitamin D), the results of pre-operative imaging (CT (computerized
      tomography) scan, 99mTc SestaMIBI Scan, 3D-Vitual Neck Exploration (VNE)), the operative data
      (the surgical approach, the localization and the dimensions of the adenoma (s), the necessity
      to convert to classical approach and its reason, the values of the intra operative PTH), the
      pathology results, the biological work-up at follow-up (plasma calcium, phosphor, PTH,
      vitamin D) are prospectively recorded in the database.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2019</start_date>
  <completion_date type="Anticipated">December 2029</completion_date>
  <primary_completion_date type="Anticipated">December 2029</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Accuracy of 3D-VNE (virtual neck exploration) in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a 3D-VNE</measure>
    <time_frame>Surgery time</time_frame>
    <description>(true positives + true negatives) / number of patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of 3D-VNE (virtual neck exploration) in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a 3D-VNE with positive confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Sensitivity = True Positives / (True Positives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of 3D-VNE (virtual neck exploration) in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a 3D-VNE with negative confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Specificity = True Negatives / (True Negatives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive predictive value of 3D-VNE (virtual neck exploration) in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Positive predictive value = True Positives / (True Positives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative predictive value of 3D-VNE (virtual neck exploration) in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Negative predictive value = True Negatives / (True Negatives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy of Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a Computed Tomography</measure>
    <time_frame>Surgery time</time_frame>
    <description>(True positives + True negatives) / number of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a Computed Tomography with positive confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Sensitivity = True Positives / (True Positives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a Computed Tomography with negative confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Specificity = True Negatives / (True Negatives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive predictive value of Computed Tomography in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Positive predictive value = True Positives / (True Positives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative predictive value of Computed Tomography in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Negative predictive value = True Negatives / (True Negatives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy of 99mTc SestaMIBI Scan in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a 99mTc SestaMIBI Scan</measure>
    <time_frame>Surgery time</time_frame>
    <description>(True positives + True negatives) / number of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of 99mTc SestaMIBI Scan in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a 99mTc SestaMIBI Scan with positive confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Sensitivity = True Positives / (True Positives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of 99mTc SestaMIBI Scan in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a 99mTc SestaMIBI Scan with negative confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Specificity = True Negatives / (True Negatives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive predictive value of 99mTc SestaMIBI Scan in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Positive predictive value = True Positives / (True Positives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative predictive value of 99mTc SestaMIBI Scan in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Negative predictive value = True Negatives / (True Negatives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy of cervical ultrasound in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a cervical ultrasound</measure>
    <time_frame>Surgery time</time_frame>
    <description>(True positives + True negatives) / number of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of cervical ultrasound in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a cervical ultrasound with positive confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Sensitivity = True Positives / (True Positives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of cervical ultrasound in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a cervical ultrasound with negative confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Specificity = True Negatives / (True Negatives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive predictive value of cervical ultrasound in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Positive predictive value = True Positives / (True Positives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative predictive value of cervical ultrasound in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Negative predictive value = True Negatives / (True Negatives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy of cervical MRI in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a cervical MRI</measure>
    <time_frame>Surgery time</time_frame>
    <description>(True positives + True negatives) / number of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of cervical MRI in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a cervical MRI with positive confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Sensitivity = True Positives / (True Positives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of cervical MRI in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a cervical MRI with negative confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Specificity = True Negatives / (True Negatives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive predictive value of cervical MRI in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Positive predictive value = True Positives / (True Positives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative predictive value of cervical MRI in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Negative predictive value = True Negatives / (True Negatives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients</measure>
    <time_frame>Surgery time</time_frame>
    <description>(True positives + True negatives) / number of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a Computed Tomography with positive confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Sensitivity = True Positives / (True Positives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a Computed Tomography with negative confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Specificity = True Negatives / (True Negatives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive predictive value of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Positive predictive value = True Positives / (True Positives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative predictive value of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Negative predictive value = True Negatives / (True Negatives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy of parathyroid autofluorescence detection in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a parathyroid autofluorescence</measure>
    <time_frame>Surgery time</time_frame>
    <description>(True positives + True negatives) / number of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of parathyroid autofluorescence detection in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a parathyroid autofluorescence detection with positive confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Sensitivity = True Positives / (True Positives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of parathyroid autofluorescence detection in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a parathyroid autofluorescence detection with negative confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Specificity = True Negatives / (True Negatives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive predictive value of parathyroid autofluorescence detection in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Positive predictive value = True Positives / (True Positives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative predictive value of parathyroid autofluorescence detection in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Negative predictive value = True Negatives / (True Negatives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy of Intraoperative probe-based confocal endomicroscopy in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients</measure>
    <time_frame>Surgery time</time_frame>
    <description>(True positives + True negatives) / number of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of Intraoperative probe-based confocal endomicroscopy in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients with positive confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Sensitivity = True Positives / (True Positives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of Intraoperative probe-based confocal endomicroscopy in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients with negative confirmed results</measure>
    <time_frame>Surgery time</time_frame>
    <description>Specificity = True Negatives / (True Negatives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive predictive value of Intraoperative probe-based confocal endomicroscopy in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Positive predictive value = True Positives / (True Positives + False Positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative predictive value of Intraoperative probe-based confocal endomicroscopy in indicating the localization of the parathyroid adenoma(s)</measure>
    <time_frame>Surgery time</time_frame>
    <description>Negative predictive value = True Negatives / (True Negatives + False Negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with minimally invasive parathyroidectomy approach</measure>
    <time_frame>Surgery time</time_frame>
    <description>Number of patients with minimally invasive parathyroidectomy/ total number of operated patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with classical cervicotomy parathyroidectomy approach</measure>
    <time_frame>Surgery time</time_frame>
    <description>Number of patients with classical cervicotomy parathyroidectomy/ total number of operated patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients necessitating conversion from minimally invasive parathyroidectomy approach to classical cervicotomy</measure>
    <time_frame>Surgery time</time_frame>
    <description>Number of patients necessitating conversion from minimally invasive parathyroidectomy approach to classical cervicotomy / total number of operated patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hyperparathyroidism recurrence rate</measure>
    <time_frame>1 year postoperatively</time_frame>
    <description>Number of patients with recurrent / total number of operated patients</description>
  </secondary_outcome>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Primary Hyperparathyroidism</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>3D-VNE (virtual neck exploration)</intervention_name>
    <description>The 3D-VNE model is obtained with VP Planning software (Visible Patient, Strasbourg, France), using DICOM (Digital Imaging and Communications in Medicine) images of contrasted Computed Tomography scan of the neck in operative positioning.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients, male or female, with a confirmed biological diagnosis of primary
        hyperparathyroidism and for whom preoperative or intraoperative imaging is planned
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with biochemically confirmed PHPT who are scheduled for elective
             parathyroidectomy

          2. Patient able to receive and understand trial information

          3. Patient affiliated with the French social security system

        Exclusion Criteria:

          1. Patient expressing opposition to the use, after anonymization, of medical data for
             scientific research

          2. Pregnant or breast-feeding woman

          3. Patient under guardianship or curatorship

          4. Patient under the protection of justice
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mihaela IGNAT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service Chirurgie Digestive et Endocrinienne, Nouvel HÃ´pital Civil de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Armelle Takeda, PhD</last_name>
    <phone>+33(0)390413608</phone>
    <email>armelle.takeda@ihu-strasbourg.eu</email>
  </overall_contact>
  <reference>
    <citation>Sessa L, Lombardi CP, De Crea C, Raffaelli M, Bellantone R. Video-assisted endocrine neck surgery: state of the art. Updates Surg. 2017 Jun;69(2):199-204. doi: 10.1007/s13304-017-0467-3. Epub 2017 Jun 15. Review.</citation>
    <PMID>28620896</PMID>
  </reference>
  <reference>
    <citation>D'Agostino J, Diana M, Vix M, Nicolau S, Soler L, Bourhala K, Hassler S, Wu HS, Marescaux J. Three-dimensional metabolic and radiologic gathered evaluation using VR-RENDER fusion: a novel tool to enhance accuracy in the localization of parathyroid adenomas. World J Surg. 2013 Jul;37(7):1618-25. doi: 10.1007/s00268-013-2021-x.</citation>
    <PMID>23558758</PMID>
  </reference>
  <reference>
    <citation>D'Agostino J, Diana M, Vix M, Soler L, Marescaux J. Three-dimensional virtual neck exploration before parathyroidectomy. N Engl J Med. 2012 Sep 13;367(11):1072-3. doi: 10.1056/NEJMc1201488.</citation>
    <PMID>22970967</PMID>
  </reference>
  <reference>
    <citation>D'Agostino J, Wall J, Soler L, Vix M, Duh QY, Marescaux J. Virtual neck exploration for parathyroid adenomas: a first step toward minimally invasive image-guided surgery. JAMA Surg. 2013 Mar;148(3):232-8; discussion 238.</citation>
    <PMID>23682370</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 5, 2019</study_first_submitted>
  <study_first_submitted_qc>July 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>July 5, 2019</last_update_submitted>
  <last_update_submitted_qc>July 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>primary hyperparathyroidism</keyword>
  <keyword>parathyroidectomy</keyword>
  <keyword>3D reconstruction</keyword>
  <keyword>Virtual neck exploration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Parathyroid Neoplasms</mesh_term>
    <mesh_term>Hyperparathyroidism</mesh_term>
    <mesh_term>Hyperparathyroidism, Primary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

